Cisplatin causes over-expression of tachykinin NK1 receptors and increases ERK1/2- and PKA‐ phosphorylation during peak immediate- and delayed-phase emesis in the least shrew (Cryptotis parva) brainstem

Abstract

Scant information is available regarding the effects of cisplatin on the expression profile of tachykinin NK1 receptors and downstream signaling during cisplatin-induced emesis. Cisplatin causes peak early- and delayed-phase emesis in the least shrew at 1–2 and 33h post-injection. To investigate the expression profile of NK1 receptor during both emetic phases, we cloned the cDNA corresponding to a ∼700 base pairs of mRNA flanked by two stretches of nucleotides conserved among different species and demonstrated that the shrew NK1 receptor nucleotide sequence shares ∼90% sequence identity with the human NK1 receptor. Of the 12 time-points tested, significant increases in expression levels of NK1 receptor mRNA in the shrew brainstem occurred at 2 and 28h post-cisplatin injection, whereas intestinal NK1 receptor mRNA was increased at 28h. Shrew brainstem and intestinal substance P mRNA levels also tended to increase during the two phases. Furthermore, expression levels of NK1 receptor protein were significantly increased in the brainstem at 2, 8, and 33h post-cisplatin. No change in brainstem 5-HT3 receptor protein expression was observed. The temporal enhancements in NK1 receptor protein expression were mirrored by significant increases in the phosphorylation status of the brainstem ERK1/2 at 2, 8, and 33h post-cisplatin. Phosphorylation of PKA significantly increased at 33rd and 40th hour. Our results indicate associations between cisplatin’s peak immediate- and delayed-phase vomiting frequency with increased: (1) expression levels of NK1 receptor mRNA and its protein level, and (2) downstream NK1 receptor-mediated phosphorylation of ERK1/2 and PKA signaling.